the results showed that ti inhibited cellular growth of nb4 promyelocytic leukemia cells in a time-dependent and dose-dependent manner, and treatment for 72 h induced a marked inhibition of cellular growth, showing an ic50 of 57.1 +/- 8.26 microg/ml.